Wenbin Lin

Chicago, IL, United States of America

Wenbin Lin

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 116(Granted Patents)


Location History:

  • Chapel Hill, NC (US) (2005 - 2017)
  • Chicago, IL (US) (2017 - 2024)

Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Wenbin Lin - Pioneering Cancer Therapies and Catalysis in Chicago

Introduction:

Wenbin Lin, a prolific inventor based in Chicago, IL, has made significant contributions to the fields of cancer therapy and catalysis. With a remarkable 18 patents to his name, Lin is recognized for his groundbreaking research in developing novel treatment approaches for cancer and advancing catalytic reactions through innovative materials.

Latest Patents:

Among his recent patents is the innovative method involving the combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy. This approach demonstrates synergistic anticancer efficacy, targeting resistant cancer stem cells and sensitizing cancer cells to therapy. Lin's work also extends to the development of strongly Lewis acidic metal-organic frameworks for continuous flow catalysis, which have shown promising applications in various organic group transformations.

Career Highlights:

Lin's expertise and dedication have been honed through his tenure at esteemed institutions such as the University of Chicago and the University of North Carolina at Chapel Hill. His research at these institutions has paved the way for new advancements in the fields of oncology and catalysis, garnering recognition for his innovative approaches and impactful contributions.

Collaborations:

Throughout his career, Wenbin Lin has collaborated closely with notable peers in the field, including Chunbai He and Demin Liu. These collaborations have been instrumental in driving forward cutting-edge research initiatives and fostering a collaborative spirit within the scientific community.

Conclusion:

In conclusion, Wenbin Lin stands as a pioneering figure in the realms of cancer therapy and catalysis, with a track record of innovative patents and significant contributions to the scientific community. His relentless pursuit of novel solutions and collaborative approach underscore his commitment to pushing the boundaries of innovation and making a lasting impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…